Dyslipidemia in Patients with Androgenetic Alopecia: Statins, Finasteride, or Both?

    June 2017 in “ Journal of The European Academy of Dermatology and Venereology ”
    Lidia Rudnicka, A. Rakowska
    Studysummary This meta-analysis found that patients with androgenetic alopecia have an atherogenic lipid profile, with higher LDL, triglycerides, and total cholesterol, and lower HDL, potentially explaining increased cardiovascular risk.
    Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer
    Read the full study on onlinelibrary.wiley.com →
    Discuss this study in the Community →

    Research cited in this study 3

    1. Lipid Profile in Patients with Androgenetic Alopecia: A Meta-Analysis Journal of The European Academy of Dermatology and Venereology · 2016
    2. Changes of Metabolic Profile in Men Treated for Androgenetic Alopecia with 1 mg Finasteride Endocrine Regulations · 2010
    3. Androgenetic Alopecia and Microinflammation International Journal of Dermatology · 2000

    Related research 5

    1. LB792 Minoxidil and Dutasteride Drug Tattooing for Male Androgenetic Alopecia Journal of Investigative Dermatology · 2021
    2. Dyslipidemia in Patients with Androgenetic Alopecia: Statins, Finasteride, or Both? Journal of The European Academy of Dermatology and Venereology · 2017
    3. Finasteride-Associated Melasma in a Caucasian Male PubMed · 2014
    4. Erythema Annulare Centrifugum Secondary to Treatment with Finasteride PubMed · 2007
    5. Improvement in Androgenetic Alopecia (Stage V) Using Topical Minoxidil in a Retinoid Vehicle and Oral Finasteride Archives of Dermatology · 1995